Truvada Emtricitabine and Tenofovir Disoproxil Fumarate Tablets – Wholesale & Retail (For Research Use Only)

Truvada Emtricitabine and Tenofovir Disoproxil Fumarate Tablets – Wholesale & Retail (For Research Use Only)

$1.00

Truvada Emtricitabine and Tenofovir Disoproxil Fumarate Tablets (200?mg + 300?mg) are fixed?dose combination oral film?coated tablets supplied in bottles or boxes of 30. Manufactured by Patheon Inc., Canada. Licensed under Chinese approval number HJ20200025. Pharmaceutical?grade antiviral for laboratory research and preclinical use. Wholesale and retail supported.?For wholesale prices, other specifications and uses, please consult our staff?

EMI starting from $0.00/month - View Plans
Compare
分类:

描述

Truvada Emtricitabine and Tenofovir Disoproxil Fumarate Tablets combine two potent antiretroviral agents—emtricitabine 200?mg and tenofovir disoproxil fumarate 300?mg per tablet. These synthetic nucleoside/nucleotide analogs inhibit HIV?1 reverse transcriptase and viral DNA synthesis. Widely used for treatment and prevention of HIV?1, in research it is applied to study viral replication, drug resistance, PrEP efficacy, and combination antiviral therapy. Manufactured under licence HJ20200025 by Patheon Inc., Canada, each film?coated tablet delivers precise dosing and consistent bioactivity. Supplied in packs of 30 tablets. Intended exclusively for laboratory research use only.


Product Specifications

Parameter Detail
Product Name Truvada Emtricitabine and Tenofovir Disoproxil Fumarate Tablets
Strength 200?mg emtricitabine / 300?mg tenofovir DF per tablet
Package Size 30 tablets per bottle or box
Dosage Form Film?coated tablet
Manufacturer Patheon Inc. (Canada)
Approval Number ???? HJ20200025
Drug Standard Code 86978451000101
Barcode 361958903219
CAS Number 731772?45?5
Molecular Formula combination of two APIs – emtricitabine and tenofovir DF
Molecular Weight combined molecular weight above 400 g/mol approx.

Mechanism of Action & Research Applications

Truvada Emtricitabine and Tenofovir Disoproxil Fumarate Tablets function by dual inhibition of HIV?1 reverse transcriptase and viral DNA polymerase activity, disrupting viral replication cycle. Emtricitabine acts as a cytidine analog to inhibit RT enzyme; tenofovir disoproxil fumarate is converted to tenofovir in vivo to inhibit polymerase activity. In research applications, Truvada tablets are used to model antiviral efficacy in HIV?1 infection settings, evaluate PrEP regimens, assess resistance mutations, and explore combination therapeutic strategies. Suitable for virology assays, pharmacodynamics studies, and preclinical drug screening. For laboratory research use only.


Side Effects (For Reference Only in Models)

In experimental models or preclinical references, possible observations include mild fatigue, gastrointestinal discomfort (nausea, diarrhea), headache, skin pigmentation changes, transient kidney or liver enzyme alterations, and rare metabolic acidosis. Animal or cell model results should inform dose escalation and safety monitoring.


Disclaimer

Truvada Emtricitabine and Tenofovir Disoproxil Fumarate Tablets 200?mg/300?mg are strictly intended for laboratory research use only. Not for human or veterinary therapeutic use.

其他信息

重量 20 公斤
尺寸 23 × 36 × 23 厘米

评价

目前还没有评价

成为第一个“Truvada Emtricitabine and Tenofovir Disoproxil Fumarate Tablets – Wholesale & Retail (For Research Use Only)” 的评价者

您的邮箱地址不会被公开。 必填项已用 * 标注

EMI Options

Select at least 2 products
to compare